Health News - Reduce Cholesterol. Learn about stroke, blood pressure, hyperlipidemia, diabetes, heart disease and other medical conditions.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Amino Acids: Brain Injury Treatment?

Ivanhoe Broadcast News

(Ivanhoe Newswire) -- Every 23 seconds, someone in the United States suffers a traumatic brain injury (TBI). Now researchers say they may be on the trail to new brain-restoring therapies for TBI patients.

TBI is the leading cause of death and disability in young children. Most of the time, the injuries are caused by accidents on the road, but a rising number of victims are also coming from the battlefield.

Advertisement
Related Stories
 border=
Alternative to Statins Shows Promise
Doctors Turning to Cardiac Catheterization Too Quickly
Cost of Junk Food May Influence Consumption
Related Videos
 border=
The Safety Gap: Food Fight
Recipe for a Healthy Holiday
7 Diet Roadblocks
Related Slides
 border=
Liposuction
Hyperlipidemia
Related Encyclopedia
 border=
Cholesterol

There is currently no way to treat the brain damage that causes a TBI patient's decline in memory, learning and other brain functions; but in a recent study, researchers discovered feeding amino acids to mice that suffered brain injuries helped restore their cognitive abilities. The mice received a cocktail of three branched chain amino acids (BCAAs) -- leucine, isoleucine and valine -- in their drinking water.

"We have shown in an animal model that dietary intervention can restore a proper balance of neurochemicals in the injured part of the brain, and simultaneously improve cognitive performance," Akiva S. Cohen, Ph.D., lead study author and a neuroscientist at The Children's Hospital of Philadelphia, was quoted as saying.

Earlier studies in humans show people with severe brain injuries improved mildly after receiving BCAAs intravenously. Researchers hope this new information will help unfold future therapies for TBI patients. Dr. Cohen anticipates working with other researchers within the next year on an early-phase clinical trial testing dietary BCAAs in patients with mild to moderate TBI.

Source: Proceedings of the National Academy of Sciences, published online December 7, 2009



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.


Last updated 12/10/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Mar 11, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Heart Disease Connection
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: